Literature DB >> 12095033

T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response.

F Sebille1, M Guillet, S Brouard, K Gagne, T Petzold, G Blancho, B Vanhove, J P Soulillou.   

Abstract

T cells are considered to play a major indirect role in the pathogenesis of xenograft vascular rejection, by promoting the induction of anti-donor antibodies that trigger complement- and antibody-dependent cell cytotoxicity. However, how vigorous the T cell xenoresponse is in vivo, and whether, besides their helper function, T cells are capable of directly affecting the graft is still unclear. We have previously shown that cyclosporine A (CsA) withdrawal in accommodated cardiac xenograft recipient allows for a rapid and dense T-cell infiltration, concomitant to an acute graft rejection. In this paper we further characterize the role of T cells in this rejection process and we demonstrate that adoptive transfer of CD4+ T cells in irradiated recipients of long-term cardiac xenografts is sufficient to trigger acute rejection, in the absence of any detectable induced anti-hamster antibody response. Therefore, our data suggest that unusually strong T-cell response will be another major barrier to xenotransplantation, even if antibody-mediated vascular rejection is controlled.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12095033     DOI: 10.1034/j.1600-6143.2001.010106.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  3 in total

1.  Xenotransplantation as a model of integrated, multidisciplinary research.

Authors:  Emanuele Cozzi; Erika Bosio; Michela Seveso; Domenico Rubello; Ermanno Ancona
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

2.  Xenoantigenicity of porcine decellularized valves.

Authors:  Meghana R K Helder; Nicholas J Stoyles; Brandon J Tefft; Ryan S Hennessy; Rebecca R C Hennessy; Roy Dyer; Tyra Witt; Robert D Simari; Amir Lerman
Journal:  J Cardiothorac Surg       Date:  2017-07-17       Impact factor: 1.637

3.  Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation.

Authors:  Yunhan Ma; Baiyi Xie; Junjun Guo; Yingyu Chen; Mengya Zhong; Qingru Lin; Jianyu Hua; Jiaying Zhong; Xuewei Luo; Guoliang Yan; Helong Dai; Zhongquan Qi
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.